Kantor Neurology

05/10/2025

While many are focused on microplastics & nanoplastics, we again see the risk associated with pesticides (and other environmental toxins): Read JAMA Network Open https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2833716 on proximity to golf courses and risk of by Brittany Krzyzanowski PhD; Aidan Mullan; Dorsey; Sai Shivani Chirag; Pierpaolo Turcano; Emanuele Camerucci; JAMES H. BOWER, MD; Rodolfo Savica
Barrow Neurological Institute Mayo Clinic University of Kansas Medical Center The University of Kansas

The Michael J. Fox Foundation for Parkinson's Research Parkinson's Foundation

This case-control of older US adults examines risk of Parkinson Disease by proximity of residence to a golf course.

04/05/2025

Raising , step-by-step, one day at a time — thank you Parkinson's Foundation Gateway Institute for Brain Research The Michael J. Fox Foundation for Parkinson's Research

04/02/2025

: April is Awareness Month. This year Parkinson's Foundation launched videos with — what do you think? Do you prefer http://parkinson.org/awareness or real-person (example https://youtu.be/k75EByvMkgQ?si=mMN4vtvPs2QzHqZx https://www.facebook.com/WeHealthNews) for your educational needs? The Michael J. Fox Foundation for Parkinson's Research

WeHealth interviews Daniel Kantor, MD, FAAN (VP of Clinical Research & Development at Gateway Institute for Brain Research) on questions sent in by the Parki...

03/16/2025

Thank you The Michael J. Fox Foundation for Parkinson's Research for having Gateway Institute for Brain Research exhibit as a local resource at the PD-IQ central Florida Jw Marriot Grande LakesJW Marriott. See you all at the Parkinson's Foundation Moving Day in West Palm Beach in April.

02/27/2025

What are you most excited about for in sunny West Palm Beach, FL?

Abstract Catalog is now available! · Abstract Catalog is now available! · The annual ACTRIMS Forum highlights novel and rigorous scientific discoveries made in MS that advance our understanding of research and clinical care of MS patients. The Forum 2025, themed “Making Connections,” is .....

11/28/2024

In Memoriam: Professor Giancarlo Comi - 12/15/1947 - 11/26/2024

It is with great sadness that we mourn the passing of a global giant in the field of MS. Professor Giancarlo Comi was born not far from Milan, Italy where he attended university, medical school and served in many many leadership, organizational and academic roles. He was a passionate visionary force in the field of MS who enjoyed life to the fullest. He was lecturing at conferences until his last days; the world of MS will miss him greatly.

On a personal note, he was always very supportive of the videos we filmed at conferences and was a leader who was hopeful about a future with even better MS control.

Dr. Daniel Kantor speaks with Professor Giancario Comi, Director and Chairmen of Neurology at Vita-Salute San Raffaele University about the changing strategi...

11/22/2024

Read WebMD article Top 5 Ways to Tell Memory Lapses From Dementia written by Rachel Ellis and reviewed by Dr Daniel Kantor

There are key ways to tell if your memory issues are typical ones everyone has sometimes or signs of dementia.

10/19/2024

: Session on Emerging Tools Enabling Clinical Development chaired by Mark Frasier The Michael J. Fox Foundation for Parkinson's Research - highlighted publicly-available biomarker pipeline: https://zenodo.org/communities/mjff/records?q=&l=list&p=1&s=10&sort=newest

10/18/2024

: Martin Gill on small molecule activation of TRPML1 to enhance lysosomal function and protein clearance for the therapeutic treatment of . https://www.labiotech.eu/partner/virtual-biotech-company-leveraged-data-accelerate-drug-development/

10/18/2024

: on brain-penetrant small molecule GT-02287 is well tolerated in healthy volunteers (nausea) — shows GCase target engagement. Read https://www.neurologylive.com/view/understanding-therapeutic-potential-gt-02287-gba-parkinson-disease

10/18/2024

: Angela Cacace Arvinas on Discovery of ARV-102 Oral PROTAC LRRK2 Degrader. For more on PROTAC: Magazine https://www.nature.com/articles/s41587-021-01173-2

10/18/2024

: Allyx Therapeutics on moving beyond to using mGluR5 Silent Allosteric Modulator, ALX-001 (Bristol Myers Squibb BMS-984923) — Alberto Espay, can we understand this if we don’t go all-in on “toxic” misfolded protein hypothesis that is taken for granted? [silent = no effect on glutamate]. Needed to explain away why there is actually more alpha synuclein in substantia nigra treated mice … why doesn’t that raise more questions?